In late 2022, my grandmother was officially diagnosed with Type 2 diabetes. We were fortunate enough to afford the vials of insulin she needed, but millions of other Americans aren’t as lucky. Each year, 125,000 lives are lost due to drug non-adherence—the vast majority of which is attributable to the absurd price tags on everyday pharmaceuticals.

It became clear to me that the solution was within reach: affordable generic medicines already exist for many high-demand treatments. However, several factors contribute to their underuse: